Cargando…
Therapy of cervical cancer using (131)I-labeled nanoparticles
OBJECTIVE: To evaluate the effectiveness of two kinds of Arg-Gly-Asp (RGD)-targeted (131)I-containing nanoliposomes for the treatment of cervical cancer in vitro and in vivo. METHODS: The nanoparticle liposomes designated RGD-(131)I-tyrosine peptide chain (TPC)-L and (131)I-RGD-L were prepared. The...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023049/ https://www.ncbi.nlm.nih.gov/pubmed/29658363 http://dx.doi.org/10.1177/0300060518761787 |